Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use

Completed

• Conditions: GERD

• Registration Number: NCT00691171
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of the study is to examine the impact of augmented, high-quality physician-coordinated care executed via an electronic health record (EHR)-based intervention on quality of care for gastroesophageal reflux disease (GERD) and for gastroprotection for patients on chronic non-steroidal anti-inflammatory drugs (NSAIDs) at increased risk for upper GI tract ulcers and ulcer related complications.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-01
• Study First Submitted: 2008-05-30
• Primary Completion: 2008-06
• Study Completion: 2008-06
• Study First Submitted QC: 2008-06-04
• Study First Posted: 2008-06-05
• Status Verified: 2015-04
• Last Update Submitted: 2015-04-14
• Last Update Posted: 2015-04-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 5234

Inclusion Criteria

• Eligibility as determined by criteria for participation in studies as part of the MQIC
• Agreement of participating clinical practices to undergo training in the electronic health record (EHR) intervention designed for this study

Exclusion Criteria

• Based on voluntary participation by MQIC practices, so practices were excluded if they decided to opt out

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diagnoses of GERD	After 12 months of intervention
Prescriptions for gastroprotective medicines in at-risk, chronic NSAID users	After 12 months of intervention

Secondary Outcome Measures

Name	Time	Method
NSAID-related GI complications	After 12 months of intervention
Prescriptions for GERD medications	After 12 months of intervention
Change in GERD symptoms score	After 12 months of intervention